Quick Answer
PROKIDNEY CORP. reported Stockholders Equity of -$1.01 billion for fiscal year 2025.
PROKIDNEY CORP. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$1.01B | -1.6% |
| 2024 | -$994.95M | +9.8% |
| 2023 | -$1.10B | -0.6% |
| 2022 | -$1.10B | -4174.1% |
| 2021 | $26.92M | — |
| 2021 | $0.00 | -100.0% |
| 2020 | $9.86M | -37.9% |
| 2019 | $15.88M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.01B | -2.9% | -0.6% |
| June 30, 2025 | -$1.00B | -3.1% | -0.4% |
| March 31, 2025 | -$998.55M | +8.9% | -0.4% |
| December 31, 2024 | -$994.95M | +9.8% | -1.6% |
| September 30, 2024 | -$979.71M | +10.3% | -0.8% |
| June 30, 2024 | -$972.37M | +26.5% | +11.3% |
| March 31, 2024 | -$1.10B | +31.6% | +0.7% |
| December 31, 2023 | -$1.10B | -0.6% | -1.0% |
- PROKIDNEY CORP. showed a decrease of -1.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, PROKIDNEY CORP.’s stockholders equity has declined by 6466.5% (from $15.88 million to -$1.01 billion).
- The most recent figure is from PROKIDNEY CORP.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: